Penn Cardiovascular Institute - Heart Research at Penn Contact | Cardiovascular Division | Patient Care
Home About Research Education Patient Care Members Clinical Trials News Events Funding Gifts

About the Penn Cardiovascular Institute

The University of Pennsylvania Cardiovascular Institute (Penn CVI) was established by mandate of the Dean of the School of Medicine in 2005, to build bridges between basic and translational cardiovascular scientists and clinical investigators at the University of Pennsylvania in order to generate transformational discoveries that will impact directly on cardiovascular health and disease.

Over the past decade Cardiovascular research and clinical care at the University of Pennsylvania has grown tremendously with many nationally and internationally recognized research and clinical programs. Every year since 2003, the University of Pennsylvania School of Medicine has received over $50 million in funding from the National Heart Lung and Blood Institute (NHLBI).

The Penn CVI is organized into seven research programs to promote multidisciplinary research focused in strategic areas bridging basic science and clinical investigation. The Penn CVI sponsors educational activities in the general areas of cardiovascular biology and medicine to physicians, students and the general community.

Our Mission

Promotes transformational discoveries in cardiovascular biology and medicine.

Translates discoveries in cardiovascular science and technology into innovative strategies to prevent, diagnose, treat
and ultimately cure cardiovascular diseases.

Fosters education in cardiovascular biology and medicine to physicians, students and the general community.

Creates a culture within the University of Pennsylvania and Penn Medicine where patient care, research and education
within the broad area of cardiovascular biology and medicine are seamlessly integrated.

Creating Knowledge by Building Bridges

The Penn CVI builds bridges between basic and translational cardiovascular scientists and clinical investigators at the University of Pennsylvania in order to generate transformational discoveries that will impact directly on cardiovascular health and disease at the onset of the new millennium. The strategic focus and direction of the Penn CVI is overseen by the CVI Internal Advisory Committee that includes senior faculty members from multiple Departments, Centers, Institutes and Schools at the University of Pennsylvania.

Despite remarkable advances in understanding the genetic and environmental causes of cardiovascular disease over the past fifty years, heart and vascular disease remains the leading cause of mortality in western societies. Moreover, with aging of the population and the explosion of obesity and diabetes, cardiovascular diseases are projected to become the leading cause of death on a worldwide basis for the first time in the history of the human species by the year 2020.

» Top

Pioneering Research in Cardiovascular Biology, Medicine, and Surgery

The University of Pennsylvania and Penn Medicine has a long and storied tradition of pioneering research in cardiovascular biology, medicine and surgery. Over the past decade, the University of Pennsylvania School of Medicine has established nationally recognized research programs in molecular cardiology, atherobiology and lipidology, thrombosis and haemostasis, cardiac electrophysiology and bioengineering. Over the same period, Penn Medicine and Children’s Hospital of Philadelphia have established nationally recognized cardiovascular clinical programs in cardiac electrophysiology, heart failure and transplantation, preventive cardiology and lipid management, complex aortic and valvular heart disease, congenital heart disease, vascular surgery, interventional cardiology and cardiovascular imaging. The overall goal of the Penn Cardiovascular Institute is to leverage this basic and clinical expertise in cardiovascular biology and medicine to promote discovery.

» Top

Multidisciplinary Research Teams

To promote multidisciplinary collaborative teams of investigators focused in key strategic areas bridging basic science and clinical investigation,
the Penn CVI is organized into seven research programs:

See Research Teams »

Congenital Heart Disease / Development Director: Dr. Jonathan Epstein
Prevention / Atherosclerosis / Lipids Director: Dr. Daniel Rader
Myocyte Biology / Heart Failure Co-Directors: Dr. Ken Margulies, Dr. Lee Sweeney
Cardiac Electrophysiology / Channel Biology Director: Dr. Francis Marchlinski
Biotechnology / Nanomedicine / Imaging Co-Directors: Dr. Peter Davies, Dr. R. Nick Bryan
Thrombosis / Hemostasis Co-Directors: Dr. Skip Brass, Dr. Mortimer Poncz
Pulmonary Vascular Disease Director: Dr. Steven Kawut

Each program unit brings together basic, translational and clinical investigators working to translate basic discoveries into novel preventive strategies, diagnostic modalities and treatments for cardiovascular diseases. The program units sponsor a variety of activities intended to promote this goal, including CVI seminars, journal clubs, and working meetings to plan new collaborative projects. In addition, the CVI sponsors strategically-targeted CVI pilot grants rected toward the goal of submitting multi-disciplinary program project, SCCOR and NIH Roadmap type grants.

» Top

Collaboration / Collaborative Spaces

A critical component of the Penn CVI is faculty members performing cardiovascular research are geographically contiguous (whenever possible) in adjacent spaces that serve as cardiovascular centers-of-excellence on the Penn medical campus.

The state-of-the-art Biomedical Research Building II/III on the Penn Medical campus is home of the Penn CVI Administrative Team and contains laboratories and core facilities dedicated to basic and translational cardiovascular research. Because of obvious programmatic synergies, the Institute for Diabetes, Obesity and Metabolism (IDOM) will be relocated to the 7th floor of the BRB II/III and the Institute for Translational Medicine and Therapeutics (ITMAT) is located on the 8th floor of BRB II/III. Together, these three recently established Institutes will work together to promote transformational discoveries in cardiovascular and metabolic/diabetic disease.

Cardiovascular research programs and collaborations located outside BRB II/III also fall under the Penn CVI umbrella including investigators in the Departments of: Cell and Developmental Biology, Physiology, Genetics, Pharmacology, Medicine, Surgery, Radiology, Anesthesia, Pediatrics and the Institute for Medicine and Engineering (IME) and the Center for Clinical Epidemiology and Biostatistics (CCEB).

Each of these centers, institutes and departments has a strong focus in cardiovascular research.In addition, close collaborations have been established with clinical investigators at the Hospital of the University of Pennsylvania and the Children's Hospital of Philadelphia (CHOP) in order to facilitate translational and clinical research studies.

» Top

Core Labs

See Core Labs »

Penn CVI Core Laboratories have been established that are available to faculty members of the Penn CVI performing basic, translational and clinical research. The Molecular Cardiology and Translational core facilities are located on the 9th and 10th floors of the BRBII/III building.

Penn CVI Core Laboratories include:
Histology, Transgenic/ES cell, Mouse Cardiovascular Physiology and Myocyte Function, Mouse Electrophysiology and Cardiovascular Genetics and Genomics.

Special core facilities have been constructed to promote translational research studies using large animal models of cardiovascular disease. These facilities and faculty members participating in these programs were established to build a bridge to the pharmaceutical, biotechnology and medical device industries. The Penn Laboratory for Preclinical Cardiology (PLPC) is a good laboratory practices (GLP)-certified large animal interventional cardiology laboratory that contains a state-of-the-art digital cardiac catheterization suite. It is located in the basement of the BRBII/III building. Faculty members and trainees in the Penn Cardiac Electrophysiology program perform proof-of-concept studies in the Penn Experimental Electrophysiology Laboratory that is located in the Medical Science Research Laboratories Building on the Penn-Presbyterian medical campus.

» Top

Events

See Events »

The CVI sponsors a diverse calendar of activities, including weekly CV Grand Rounds at HUP, monthly CV Grand Rounds at Presbyterian, Combined Cardiothoracic Surgery and CV Conferences, and a CVI Seminar Series which hosts nationally recognized experts performing molecular, translational and clinical cardiovascular research. On May 28, 2008 the Penn CVI hosted its First Annual Symposium on Cardiovascular Development and Disease, featuring noted cardiovascular scientist Dr. Elizabeth Nabel, Director of the NHLBI, and many other leaders in the field.

» Top

Educational Programs

See Educational Programs »

The Penn CVI also promotes educational programs in cardiovascular biology and medicine to physicians, students and the general community. This includes the Penn CVI NIH-sponsored Training Program in Cardiovascular Biology and Medicine and the CCEB-sponsored Training Program in Clinical Cardiology and Pulmonary Research. Penn CVI faculty members lecture and oversee Cardiovascular Workshops as part of the Cardiovascular Block of Curriculum 2000, the undergraduate medical student core curriculum.

Penn CVI faculty members direct ABIM-accredited fellowship training programs in Cardiovascular Medicine, Cardiac Electrophysiology and Interventional Cardiology as well as Cardiothoracic Surgery and Vascular Surgery. In addition, CVI faculty members direct multiple CME courses focused on multiple topics relevant to cardiovascular medicine and cardiothoracic surgery. CVI faculty members also present lectures on cardiovascular health and disease to interested patients in the community at our outpatient satellite practices at Penn Medicine at Radnor and Penn Medicine at Cherry Hill.

» Top